George Polimenakos

Tilray's CBD100 Approved For Clinical Trials In Australia And New Zealand By The Natural Health Science Foundation

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has received approval and verification from The Natural Health Science Foundation ("NHSF") of its flagship product, Tilray Purifi

Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform

Marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Tuesday the expansion of its medical cannabis product offering in Australia and the launch of a new medical cannabis e-learning platform for healthcare providers.